Aethlon Medical (AEMD) Equity Average (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Equity Average for 14 consecutive years, with $5.2 million as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Equity Average fell 42.26% year-over-year to $5.2 million, compared with a TTM value of $5.2 million through Dec 2024, down 42.26%, and an annual FY2024 reading of $10.4 million, down 35.02% over the prior year.
- Equity Average was $5.2 million for Q4 2024 at Aethlon Medical, down from $7.4 million in the prior quarter.
- Across five years, Equity Average topped out at $23.8 million in Q3 2021 and bottomed at $5.2 million in Q4 2024.
- Average Equity Average over 5 years is $13.3 million, with a median of $13.3 million recorded in 2020.
- The sharpest move saw Equity Average skyrocketed 2667.81% in 2020, then tumbled 58.64% in 2024.
- Year by year, Equity Average stood at $12.5 million in 2020, then surged by 73.83% to $21.7 million in 2021, then dropped by 14.52% to $18.6 million in 2022, then crashed by 51.73% to $9.0 million in 2023, then crashed by 42.26% to $5.2 million in 2024.
- Business Quant data shows Equity Average for AEMD at $5.2 million in Q4 2024, $7.4 million in Q3 2024, and $7.2 million in Q2 2024.